Jared Barrera - 12 May 2025 Form 4 Insider Report for Kindly MD, Inc. (KDLY)

Reporting relationship: CFO
Issuer ticker: KDLY
Reported as of: 12 May 2025
Net transaction value: +$136,500
SEC form: 4
Accepted by SEC: 14 May 2025, 20:15:24 UTC
Prior SEC filing: 13 May 2024
Next SEC filing: 24 Sep 2025
Source filing: View source filing
Reporting owner signature: /s/ Jared Barrera

Key filing fact

Jared Barrera filed Form 4 for Kindly MD, Inc. (KDLY) on 14 May 2025.

Key facts

This page summarizes Jared Barrera's Form 4 filing for Kindly MD, Inc. (KDLY).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 14 May 2025, 20:15.

Change

Previous filing in this sequence was filed on 13 May 2024.
Current net transaction value: +$136,500.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002002864 Primary reporting owner

Barrera Jared

Relationship: CFO
Address: 5097 SOUTH 900 EAST, SALT LAKE CITY,
Signature: /s/ Jared Barrera
Signature date: 14 May 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KDLY transaction Derivative

Option

Award

Transaction value: $136,500
Shares: +35,000
Change %: +193%
Price: $3.90
Shares after: 53,147
Date: 12 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 35,000
Exercise price: $3.90
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These options vest proportionally over a nine-month period ending January 31, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .